Low back pain

Rebecca Brown; Avniel Klein; Alex Visco; Joseph E. Herrera

doi:10.1007/978-1-59745-247-2_4

Low back pain

Rebecca Brown, Avniel Klein, Alex Visco, Joseph E. Herrera

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Low back pain (LBP) is the most common musculoskeletal complaint in the general population. It is one of the major reasons patients seek medical evaluation (1), second only to upper respiratory illness (2,3). Approximately 50 to 90% of the adult population will suffer from pain related to their back during their lifetime (4,5). Each year, 15 to 45% of adults suffer LBP, and 1 out of 20 people present to the hospital with a new episode of back pain.

Original language	English
Title of host publication	Therapeutic Uses of Botulinum Toxin
Publisher	Humana Press
Pages	39-59
Number of pages	21
ISBN (Print)	9781588299147
DOIs	https://doi.org/10.1007/978-1-59745-247-2_4
State	Published - 2007

Access to Document

10.1007/978-1-59745-247-2_4

Cite this

@inbook{c1867899762b4faf970374c0366afd67,

title = "Low back pain",

abstract = "Low back pain (LBP) is the most common musculoskeletal complaint in the general population. It is one of the major reasons patients seek medical evaluation (1), second only to upper respiratory illness (2,3). Approximately 50 to 90\% of the adult population will suffer from pain related to their back during their lifetime (4,5). Each year, 15 to 45\% of adults suffer LBP, and 1 out of 20 people present to the hospital with a new episode of back pain.",

author = "Rebecca Brown and Avniel Klein and Alex Visco and Herrera, \{Joseph E.\}",

year = "2007",

doi = "10.1007/978-1-59745-247-2\_4",

language = "English",

isbn = "9781588299147",

pages = "39--59",

booktitle = "Therapeutic Uses of Botulinum Toxin",

publisher = "Humana Press",

address = "United States",

}

TY - CHAP

T1 - Low back pain

AU - Brown, Rebecca

AU - Klein, Avniel

AU - Visco, Alex

AU - Herrera, Joseph E.

PY - 2007

Y1 - 2007

N2 - Low back pain (LBP) is the most common musculoskeletal complaint in the general population. It is one of the major reasons patients seek medical evaluation (1), second only to upper respiratory illness (2,3). Approximately 50 to 90% of the adult population will suffer from pain related to their back during their lifetime (4,5). Each year, 15 to 45% of adults suffer LBP, and 1 out of 20 people present to the hospital with a new episode of back pain.

AB - Low back pain (LBP) is the most common musculoskeletal complaint in the general population. It is one of the major reasons patients seek medical evaluation (1), second only to upper respiratory illness (2,3). Approximately 50 to 90% of the adult population will suffer from pain related to their back during their lifetime (4,5). Each year, 15 to 45% of adults suffer LBP, and 1 out of 20 people present to the hospital with a new episode of back pain.

UR - https://www.scopus.com/pages/publications/84892347127

U2 - 10.1007/978-1-59745-247-2_4

DO - 10.1007/978-1-59745-247-2_4

M3 - Chapter

AN - SCOPUS:84892347127

SN - 9781588299147

SP - 39

EP - 59

BT - Therapeutic Uses of Botulinum Toxin

PB - Humana Press

ER -

Low back pain

Abstract

Access to Document

Fingerprint

Cite this